Ketamine Nasal Spray Relieves Suicidal Thoughts, but Doctors Worry About Abuse Risk

Gizmodo --------- Ketamine, a drug that’s been retooled as a “breakthrough” in depression treatment, is one step closer to becoming mainstream medicine, thanks to the results of a Phase II clinical trial published this week in the American Journal of Psychiatry. But some experts are wary of creating a new drug-abuse crisis by introducing a potentially addictive drug to millions of new users. To learn more click on the picture below to read the article.